Irving, TX – (June 17, 2008) – RBC Life Sciences Inc. (OTCBB: RBCL) held a very successful North American Summit in Dallas, Texas June 6 – 7. The Company's Independent Associates converged on the Embassy Suites Outdoor World to hear from RBC executives, peers and field leaders about new products being offered to the market place. Among the products discussed was OliViva. OliViva is RBC's new functional beverage made from a proprietary blend of fresh olive leaf complex and six other legendary botanicals. It has the antioxidant power of six servings of fruits and vegetables in just one ounce.
The North American Summit attracted record attendance and was the Company's largest event in a number of years, with Associates from across North America. "The success of the event is a key indicator that we are on the right track in our market. Our Associates expressed overwhelming support and enthusiasm for the new products, including the newly introduced Spirulina Whole Food Bar," said John Price, President of RBC. "Our foundation is whole food and natural nutrition, manufactured to our strict guidelines, using our proprietary ingredients and adhering to Good Manufacturing Practices (GMP)."
"The Summit afforded us the opportunity to launch the new Spirulina bars to a group of product consumers who demand the very best, and they got it," stated Kevin Young, Director of Sales. From the early days of Spirulina's introduction to the market by Dr. Christopher Hills, to today's launch of the Whole Food Bar, RBC has worked to keep "nature's most complete food" a viable, affordable supplement to the consuming public. The bars will go on sale in early July.
Additionally, RBC will convene for a National Training Weekend during October 2008, in Los Angeles, California. Associates will be educated and trained on how to use the Company's products in their healthy lifestyles and how to share the benefits with others.
RBC Life Sciences develops, manufactures and markets high quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.
The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
Contacts:
Halliburton Investor Relations, 972-458-8000
search blogs
share it
blog it
